Prognostic Relevance of the Lung Ultrasound Score: A Multioutcome Study in Infants with Respiratory Distress Syndrome.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Source:
      Publisher: Thieme-Stratton Country of Publication: United States NLM ID: 8405212 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1098-8785 (Electronic) Linking ISSN: 07351631 NLM ISO Abbreviation: Am J Perinatol Subsets: MEDLINE
    • Publication Information:
      Original Publication: New York, NY : Thieme-Stratton, 1983-
    • Subject Terms:
    • Abstract:
      Objective: There is growing evidence for the usefulness of the lung ultrasound score (LUS) in neonatal intensive care. We evaluated whether the LUS is predictive of outcomes in infants with respiratory distress syndrome (RDS).
      Study Design: Neonates less than 34 weeks of gestational age were eligible for this prospective, multicenter cohort study. The outcomes of interest were the need for mechanical ventilation (MV) at <72 hours of life, the need for surfactant (SF), successful weaning from continuous positive airway pressure (CPAP), extubation readiness, and bronchopulmonary dysplasia. Lung scans were taken at 0 to 6 hours of life (Day 1), on Days 2, 3, and 7, and before CPAP withdrawal or extubation. Sonograms were scored (range 0-16) by a blinded expert sonographer. The area under the receiver operating characteristic curve (AUC) was used to estimate the prediction accuracy of the LUS.
      Results: A total of 647 scans were obtained from 155 newborns with a median gestational age of 32 weeks. On Day 1, a cutoff LUS of 6 had a sensitivity (Se) of 88% and a specificity (Sp) of 79% to predict the need for SF (AUC = 0.86), while a cutoff LUS of 7 predicted the need for MV at <72 hours of life (Se = 89%, Sp = 65%, AUC = 0.80). LUS acquired prior to weaning off CPAP was an excellent predictor of successful CPAP withdrawal, with a cutoff level of 1 (Se = 67%, Sp = 100%, AUC = 0.86).
      Conclusion: The LUS has significant predictive ability for important outcomes in neonatal RDS.
      Key Points: · Lung ultrasound has significant prognostic abilities in neonatal RDS.. · Early sonograms (0-6 h of life) accurately predict the requirement for SF and ventilation.. · Weaning off CPAP is effective when the LUS (range 0-16) is less than or equal to 1..
      Competing Interests: P.S., M.S., W.B., I.S-K., P.K., and R.B. received honoraria from Chiesi Poland for lecturing and participation on advisory boards. R.H. is employed by Chiesi Poland, the sponsor of the study. The remaining authors report no conflict of interest.
      (The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).)
    • References:
      J Perinatol. 2021 Jan;41(1):62-68. (PMID: 32665687)
      Ann Am Thorac Soc. 2022 Apr;19(4):659-667. (PMID: 34788582)
      Eur J Pediatr. 2021 Sep;180(9):2781-2789. (PMID: 33755776)
      Arch Dis Child Fetal Neonatal Ed. 2021 Nov;106(6):657-662. (PMID: 33990385)
      Pediatr Pulmonol. 2022 Sep;57(9):2128-2135. (PMID: 35652432)
      Am J Respir Crit Care Med. 2019 Sep 15;200(6):751-759. (PMID: 30995069)
      Pediatr Pulmonol. 2020 Sep;55(9):2452-2456. (PMID: 32609928)
      EClinicalMedicine. 2022 Dec 22;55:101791. (PMID: 36712892)
      Pediatr Pulmonol. 2021 Jul;56(7):2073-2080. (PMID: 33819393)
      Chest. 2021 Sep;160(3):1006-1016. (PMID: 33689782)
      Am J Respir Crit Care Med. 2021 Jun 1;203(11):1398-1409. (PMID: 33352083)
      JAMA Pediatr. 2015 Aug;169(8):e151797. (PMID: 26237465)
      Eur J Pediatr. 2020 Dec;179(12):1909-1911. (PMID: 32710303)
      J Clin Ultrasound. 2022 Nov;50(9):1322-1327. (PMID: 35353383)
      J Pediatr. 2021 Nov;238:187-192.e2. (PMID: 34237347)
      Cancer. 1950 Jan;3(1):32-5. (PMID: 15405679)
      Pediatr Pulmonol. 2023 Feb;58(2):530-539. (PMID: 36324211)
      BMC Pediatr. 2021 Jan 6;21(1):17. (PMID: 33407270)
      Front Pediatr. 2021 Dec 06;9:709160. (PMID: 34938695)
      Pediatrics. 2018 Sep;142(3):. (PMID: 30108142)
      Pediatr Pulmonol. 2019 Sep;54(9):1404-1409. (PMID: 31216121)
      Pediatr Pulmonol. 2022 Sep;57(9):2227-2236. (PMID: 35670034)
      Am J Respir Crit Care Med. 2001 Jun;163(7):1723-9. (PMID: 11401896)
      J Pediatr. 2018 Jun;197:300-308. (PMID: 29551318)
      Eur J Pediatr. 2022 Aug;181(8):3013-3021. (PMID: 35648231)
      Neonatology. 2019;115(4):432-450. (PMID: 30974433)
      Am J Perinatol. 2019 Nov;36(13):1357-1361. (PMID: 30609427)
      Ultraschall Med. 2023 Jun;44(3):240-268. (PMID: 36669528)
      Eur J Pediatr. 2021 Mar;180(3):869-876. (PMID: 32949291)
      Neonatology. 2023;120(1):3-23. (PMID: 36863329)
      J Pediatr. 2019 Sep;212:137-143.e1. (PMID: 31079857)
      Am J Perinatol. 2021 Jan;38(2):176-181. (PMID: 31480084)
    • Accession Number:
      0 (Pulmonary Surfactants)
    • Publication Date:
      Date Created: 20231017 Date Completed: 20240605 Latest Revision: 20240730
    • Publication Date:
      20240731
    • Accession Number:
      PMC11150063
    • Accession Number:
      10.1055/s-0043-1775975
    • Accession Number:
      37848043